“Efficacy and Safety of Roflumilast Cream 0.15% in Adults and Children Aged ≥6 Years With Mild to Moderate Atopic Dermatitis in Two Phase 3 Trials (INTEGUMENT-1 and INTEGUMENT-2)”. SKIN The Journal of Cutaneous Medicine, vol. 7, no. 4, July 2023, p. s220, https://doi.org/10.25251/skin.7.supp.220.